Bebac.at

BEBAC. Consultancy Services for Bioequivalence and Bioavailability Studies – Ing. Helmut Schütz

What’s new on Bebac.at: Check updates and related news right now. This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Bebac.at popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to BEBAC

Subscribe to related news

Big Pharma quietly enlists leading professors to justify $1,000-per-day drugs
via patriotrising

Over the last three years, pharmaceutical companies have mounted a public relations blitz to tout new cures for the hepatitis C virus and persuade insurers, including government programs such as Medicare and Medicaid, to cover the costs. That isn’t an...
Special Report: A World of Difference — Biosimilars and Biobetters Offer Unique Benefits — and Risks
via bioprocessintl

by John Otrompke, with Cheryl Scott and S. Anne Montgomery When the United States Food and Drug Administration (FDA) approved the country’s first ever biosimilar on 6 March 2015, it had been a long time coming. After all, the European Union had approved...
Use Only as Directed
via nbc10

During the last decade, more than 1,500 Americans died after accidentally taking too much of a drug renowned for its safety: acetaminophen, one of the nation’s most popular pain relievers. Acetaminophen – the active ingredient in Tylenol...
LSPPPO|HEALTHCARE NEWS|October 10, 2013
via elbiruniblogspotcom.blogspot

LSPPPO|HEALTHCARE NEWS|October 03, 2013 Healthcare News A Weekly Compilation of Clinical Laboratory and Related Information from The Division of Laboratory Science and Standards October 10, 2013 News Highlights CDC Director: ‘Microbes Didn...
Gw Pharmaceuticals Plc Reports Fourth Quarter And Year-End 2015 Financial Results And Operational Progress
via whotrades.olanola

The following excerpt is from the company's SEC filing. - Three Phase 3 Epidiolex clinical trials fully recruited above target sample size – on track for initial data in Q1 2016 - - Significant clinical activity in multiple cannabinoid pipeline programs...